Cancers of the Colon, Pancreas, Esophagus, Stomach

Show Only Open Trials
2.

Phase I Study of Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy in Patients With Resectable Esophageal Cancer

  • Study Status: Open to Enrollment
  • Sponsor: Weill Cornell Medical College
  • Disease Status and/or Stage: Resectable Cancer of the Esophagus or Gastroesophageal Junction (GEJ)
3.

A Randomized, Double Blind Placebo Controlled Phase 2 Study of FOLFOX Plus or Minus GDC-0449 in Patients With Advanced Gastric and Gastroesophageal Junction (GEJ) Carcinoma

  • Study Status: Closed to Enrollment
  • Sponsor: New York Cancer Consortium
  • Disease Status and/or Stage: Gastric or Gastroesophageal Junction (GEJ) Cancer Not Amenable to Surgical Resection
5.

A Phase 1B, Open-Label, Dose Escalation Study Evaluating the Safety of BSI-201 in Combination with Chemotherapeutic Regimens in Subjects with Advanced Solid Tumors

  • Study Status: Closed to Enrollment
  • Sponsor: BiPar Sciences
  • Disease Status and/or Stage: Metastatic Pancreatic Cancer
6.

A Phase Ib Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Patients With Previously Untreated Advanced Pancreatic Cancer.

  • Study Status: Closed to Enrollment
  • Sponsor: Immunomedics, Inc.
  • Disease Status and/or Stage: Untreated Advanced Pancreatic Cancer

Top of page